Lithium Use, Nephrogenic Diabetes Insipidus
1 clinical trials · Condition
◉ Watch Lithium Use, Nephrogenic Diabetes Insipidus
| Record | Firm | Date |
|---|---|---|
| Atorvastatin for the Treatment of Lithium-Induced Nephrogenic Diabetes Insipidus (NCT02967653) | Lady Davis Institute | 2017-07-13 |
Track Lithium Use, Nephrogenic Diabetes Insipidus automatically
Every clearance here is in the API, with alerts when new ones post.